Medbox to Consult on Second Marijuana Dispensary In the State of Washington

LOS ANGELES, CA / ACCESSWIRE / September 28, 2015 / Medbox, Inc. (OTCQB: MDBX), a provider of specialized services to the cannabis sector, including operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved, today announced it will provide specialized consulting services to the principals and operators of the Fweedom Collective medical dispensary on the opening of their second marijuana dispensary in the state of Washington.

The new 502 recreational retail dispensary will be located in Mountlake Terrace, Washington, and is scheduled to be operational by mid-2016. The agreement follows an earlier engagement under which Medbox is providing similar services to the principals of the Fweedom Collective for the opening of a dispensary in Mt. Vernon, WA, which is scheduled to be operational in the first half of 2016.

As with the Mt. Vernon property, Medbox will provide both pre- and post-opening services, including advising on regulatory compliance, security, training, IT and associated matters. Under the exclusive supervision and control of the Fweedom owners, the Mountlake Terrace dispensary also is expected to sell the new miVape personal vaporizer, which is produced by Medbox’s Vaporfection subsidiary.

“It is gratifying to have been selected for a second time by the principals of Fweedom, attesting to the solid relationship we are building,” said Jeff Goh, President and interim Chief Executive Officer of Medbox. “Both organizations have the same values for adhering to the highest standards of quality and professionalism.”

“We are off to an excellent start on our initial project in Mt. Vernon, and look forward to continuing to work closely with Medbox as we expand in Washington state, where marijuana has been approved both for medical and recreational use,” added J. Tyler Godfrey, one of the principals of Fweedom.

About Fweedom Collective

Founded in 2008 in Seattle, Fweedom, which currently operates a medical marijuana dispensary, started as a hemp alternative-based clothing company, bringing awareness to consumers of hemp and fabrics opposed to traditional cotton. The company evolved into a medical marijuana collective in 2011.

​About Medbox, Inc.

Medbox, Inc., a leader in the rapidly emerging cannabis sector, provides specialized services to operators of dispensaries, cultivation centers, manufacturers and research facilities in those states where approved. Through trusted clients and affiliates, the company promotes efficient, consistent, high quality products that are priced right, readily available and safely packaged. For more information about the company or to explore partnership, please visit www.medbox.com.

Forward-Looking Statements

Certain statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements, including, but not limited to, the timing of the opening of the new Mountlake Terrace dispensary, are based on current beliefs and expectations and are inherently subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the company’s control. In addition, certain forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties also include, but are not limited to, regulatory developments in the industry, as well as political and economic conditions present within the industry. For a more detailed description of the risk factors associated with the company, please refer to the company’s latest Annual Report on Form 10-K, and in particular, the section entitled “Risk Factors” therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. The company does not assume any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made, unless required by law.

For more information, contact:

Janet Simmons
PondelWilkinson Inc.
310-279-5980
pwinvestor@pondel.com

SOURCE: Medbox, Inc.

ReleaseID: 432263